Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 371

1.

Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.

Holguín Á, Yebra G, Martín L, de Pineda AT, Ruiz LE, Quezada AY, Nieto AI, Escobar G.

Clin Microbiol Infect. 2013 Dec;19(12):E523-32. doi: 10.1111/1469-0691.12264. Epub 2013 Jun 19.

2.

Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.

Murillo W, Lorenzana de Rivera I, Albert J, Guardado ME, Nieto AI, Paz-Bailey G.

J Med Virol. 2012 Oct;84(10):1514-21. doi: 10.1002/jmv.23381.

PMID:
22930496
3.

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.

de Mulder M, Yebra G, Martín L, Prieto L, Mellado MJ, Rojo P, Muñoz-Fernández MÁ, Jiménez de Ory S, Ramos JT, Holguín A; Madrid cohort of HIV-infected children.

J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305. Epub 2011 Aug 2.

PMID:
21810838
4.

Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.

Onywera H, Maman D, Inzaule S, Auma E, Were K, Fredrick H, Owiti P, Opollo V, Etard JF, Mukui I, Kim AA, Zeh C.

PLoS One. 2017 Feb 8;12(2):e0171124. doi: 10.1371/journal.pone.0171124. eCollection 2017.

5.

Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.

Drescher SM, von Wyl V, Yang WL, Böni J, Yerly S, Shah C, Aubert V, Klimkait T, Taffé P, Furrer H, Battegay M, Ambrosioni J, Cavassini M, Bernasconi E, Vernazza PL, Ledergerber B, Günthard HF, Kouyos RD; Swiss HIV Cohort Study.

Clin Infect Dis. 2014 Jan;58(2):285-94. doi: 10.1093/cid/cit694. Epub 2013 Oct 21.

PMID:
24145874
6.

Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.

Zhao B, Han X, Xu J, Hu Q, Chu Z, Zhang J, Lu L, Wang Z, Fu J, Chen X, Yan H, Zhuang M, Wang L, Sun A, Zhang CM, Shang H.

J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):250-5. doi: 10.1097/QAI.0000000000000467.

PMID:
25469530
7.

Prevalence and patterns of HIV transmitted drug resistance in Guatemala.

Avila-Ríos S, Mejía-Villatoro CR, García-Morales C, Soto-Nava M, Escobar I, Mendizabal R, Girón A, García L, Reyes-Terán G.

Rev Panam Salud Publica. 2011 Dec;30(6):641-8.

8.

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, Rinke de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW.

PLoS Med. 2015 Apr 7;12(4):e1001810. doi: 10.1371/journal.pmed.1001810. eCollection 2015 Apr. Erratum in: PLoS Med. 2015 Jun;12(6):e1001845.

9.

Short communication: HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake Victoria.

Nazziwa J, Njai HF, Ndembi N, Birungi J, Lyagoba F, Gershim A, Nakiyingi-Miiro J, Nielsen L, Mpendo J, Nanvubya A, Debont J, Grosskurth H, Kamali A, Seeley J, Kaleebu P; Chivtum Study Team.

AIDS Res Hum Retroviruses. 2013 May;29(5):788-95. doi: 10.1089/AID.2012.0123.

10.

High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.

Franzetti M, Lai A, Simonetti FR, Bozzi G, De Luca A, Micheli V, Meraviglia P, Corsi P, Bagnarelli P, Almi P, Zoncada A, Balotta C.

J Antimicrob Chemother. 2012 May;67(5):1250-3. doi: 10.1093/jac/dks013. Epub 2012 Feb 1.

PMID:
22302564
11.

Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.

Kleyn TJ, Liedtke MD, Harrison DL, Lockhart SM, Salvaggio MR, Ripley TL, Rathbun RC.

Ann Pharmacother. 2014 Apr;48(4):470-5. doi: 10.1177/1060028013519246. Epub 2014 Jan 28.

PMID:
24473489
12.

Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.

Ceccarelli L, Salpini R, Moudourou S, Cento V, Santoro MM, Fokam J, Takou D, Nanfack A, Dori L, Torimiro J, Sarmati L, Andreoni M, Perno CF, Colizzi V, Cappelli G.

J Med Virol. 2012 May;84(5):721-7. doi: 10.1002/jmv.23244.

PMID:
22431019
13.

Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989-2009.

Holguín A, Erazo K, Escobar G, de Mulder M, Yebra G, Martín L, Jovel LE, Castaneda L, Pérez E; Proyecto Esther.

Pediatr Infect Dis J. 2011 May;30(5):e82-7. doi: 10.1097/INF.0b013e3182117289.

PMID:
21326132
14.

Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.

Santos LA, Monteiro-Cunha JP, Araujo AF, Brites C, Galvao-Castro B, Alcantara LC.

J Med Virol. 2011 Dec;83(12):2066-72. doi: 10.1002/jmv.22170.

PMID:
22012712
15.

New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.

Zhao B, Han X, Dai D, Liu J, Ding H, Xu J, Chu Z, Bice T, Diao Y, Shang H.

AIDS Res Hum Retroviruses. 2011 Oct;27(10):1047-53. doi: 10.1089/AID.2010.0119. Epub 2011 May 6.

PMID:
21417755
16.

Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.

de Mulder M, Yebra G, Navas A, Martin L, de Jose MI, Navarro ML, de Ory SJ, Gonzalez-Granado I, Mellado MJ, Ramos JT, Holguin A.

Pediatr Infect Dis J. 2012 Nov;31(11):e213-21. doi: 10.1097/INF.0b013e3182678c7c.

PMID:
22785049
17.

Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.

Romero A, Sued O, Puig T, Esteve A, Pumarola T, Casabona J, González V, Matas L, Tural C, Rodrigo I, Margall N, Domingo P, Casanova A, Ferrer E, Caballero E, Ribera E, Farré J, Puig T, Amengual MJ, Navarro G, Prat JM, Masabeu A, Simó JM, Villaverde CA, Barrufet P, Sauca MG, Ortin X, Ortí A, Navarro R, Euras JM, Vilaró J, Villà MC, Montull S, Vilanova C, Pujol F, Díaz O, Miró JM; AERI study Group.

Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):482-9. doi: 10.1016/j.eimc.2011.03.001. Epub 2011 May 2.

PMID:
21543135
18.

[Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].

Yalçınkaya T, Köse S.

Mikrobiyol Bul. 2014 Oct;48(4):585-95. Turkish.

19.

HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA.

de Mulder M, York VA, Wiznia AA, Michaud HA, Nixon DF, Holguin A, Rosenberg MG.

HIV Med. 2014 Mar;15(3):135-43. doi: 10.1111/hiv.12089. Epub 2013 Sep 25.

20.

Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.

Yaotsè DA, Nicole V, Roch NF, Mireille PD, Eric D, Martine P.

Infect Genet Evol. 2009 Jul;9(4):646-52. doi: 10.1016/j.meegid.2009.04.002. Epub 2009 Apr 15.

PMID:
19460333

Supplemental Content

Support Center